AbbVie's Stock Surge: Skyrizi & Rinvoq Power Growth episode artwork

EPISODE · May 4, 2026 · 1 MIN

AbbVie's Stock Surge: Skyrizi & Rinvoq Power Growth

from The Daily News Now! Business

AbbVies stock surged after their first-quarter update, with revenue hitting $15 billion, a 12.4% increase from last year. The companys immunology segment, led by Skyrizi and Rinvoq, is driving growth, with sales guidance raised multiple times. Label expansions and strong patents are also boosting investor confidence. Despite a recent dip, AbbVies robust pipeline and Dividend King status make it a solid hold. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/7ddc2db27d56aee7

NOW PLAYING

AbbVie's Stock Surge: Skyrizi & Rinvoq Power Growth

0:00 1:11

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Daily News Now! Business?

This episode is 1 minute long.

When was this The Daily News Now! Business episode published?

This episode was published on May 4, 2026.

What is this episode about?

AbbVies stock surged after their first-quarter update, with revenue hitting $15 billion, a 12.4% increase from last year. The companys immunology segment, led by Skyrizi and Rinvoq, is driving growth, with sales guidance raised multiple times....

Can I download this The Daily News Now! Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!